Loss of BRCA2 is Linked to Poor Outcomes in Breast Cancer
Author Information
Author(s): J van den Berg, O Johannsson, S Hakansson, H Olsson, A Borg
Primary Institution: Department of Oncology, University Hospital, Lund, Sweden
Hypothesis
Is allelic loss at chromosome 13q12 - q13 associated with poor prognosis in breast cancer?
Conclusion
The study found that loss of heterozygosity at the BRCA2 locus is significantly correlated with poor prognosis in breast cancer.
Supporting Evidence
- 34% of tumors showed loss of heterozygosity at the BRCA2 region.
- 80% of rapidly proliferating tumors had LOH at BRCA2.
- LOH at BRCA2 was significantly correlated with early recurrence and death.
Takeaway
If a part of the DNA that helps prevent cancer is missing, it can make the cancer worse and lead to more serious problems.
Methodology
The study analyzed loss of heterozygosity in 84 primary breast cancer tumors using microsatellite markers.
Limitations
The study does not provide conclusive evidence that BRCA2 is the sole target for deletions at 13q12-ql3 in breast tumors.
Participant Demographics
Patients aged 26-80 years, categorized into hereditary, familial, and sporadic breast cancer.
Statistical Information
P-Value
0.001
Confidence Interval
1.3-13
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website